NDC 57319-528 - AMINO ACID ORAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57319-528
- Package NDCs from labels
- 57319-528-04
- Manufacturer
- Clipper Distributing Company, LLC | Sparhawk Laboratories, Inc.
- Effective date
- 2024-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMINO ACID ORAL SOLUTION | Clipper Distributing Company, LLC | Sparhawk Laboratories, Inc. | 2024-06-05 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57319-528-04 | AMINO ACID ORAL | 500 mL in 1 BOTTLE | SOLUTION | 500 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DPT-TOX | DROSERA, ECHINACEA, HYPERICUM, KALI MUR, MEZEREUM, SILICEA, THUJA | Nutrition Center Inc dba Nutri-West dba Micro-West | 5e39f4e6-939f-4b71-9cc5-6d4b8711ea32 | 2026-02-04 | Warnings | 660YQ98I10 |
| Epsom Salt | MAGNESIUM SULFATE | Discount Drug Mart | b05a94d2-5cc6-4989-9fb8-096e54fa7852 | 2026-02-04 | Warnings, Adverse reactions | SK47B8698T |
| Epsom Salt | MAGNESIUM SULFATE | Grocery Outlet, Inc. | 3dff4b00-e71a-1dc0-e063-6394a90a715f | 2026-02-04 | Warnings, Adverse reactions | SK47B8698T |
| Epsom Salt | MAGNESIUM SULFATE | HARRIS TEETER | 73065a04-b7cd-437d-9624-f845f5ec93bf | 2026-02-04 | Warnings, Adverse reactions | SK47B8698T |
| Epsom Salt | MAGNESIUM SULFATE | Hy-Vee, Inc. | 44592ee0-13dd-57b1-e063-6394a90ab402 | 2026-02-04 | Warnings, Adverse reactions | SK47B8698T |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 5c2e888c-2f1e-4d5a-a456-20774ca83302 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7d74652b-3513-4ebb-8b47-10b3603d04a7 | 2026-02-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Epsom Salt | MAGNESIUM SULFATE | CVS Pharmacy, Inc. | a78d991a-ba21-4bc4-b8f9-f8dafbddc28f | 2026-02-03 | Warnings, Adverse reactions | SK47B8698T |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Rising Pharma Holdings, Inc. | 947c11ca-ca0c-42df-8cc5-3db06458ca5b | 2026-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| SUTAB | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | c020e973-dccf-4862-999e-17db6209a48a | 2026-01-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | LX22YL083G |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE HEPTAHYDRATE | Sun Pharmaceutical Industries, Inc. | efadcb55-f935-4c60-b2e2-0a76b9194b50 | 2026-01-29 | Warnings, Adverse reactions | SK47B8698T |
| POKONZA potassium chloride | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 2d938cbf-27aa-4f9c-a582-5564d3b72465 | 2026-01-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | ProPharma Distribution | 48c0ee87-f722-1a71-e063-6394a90a72d1 | 2026-01-19 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 755a4a08-04ff-d7d1-a6fc-b8aeff3ae2c6 | 2026-01-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | B. Braun Medical Inc. | 7dff29d9-522d-40eb-a9d9-42377912d640 | 2026-01-14 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | Advagen Pharma Limited | d528c0c1-b81f-4f7a-8518-e6911b23c3eb | 2026-01-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Fresenius Kabi USA, LLC | e921a46b-9a5b-4163-9c88-224247541f14 | 2026-01-13 | Warnings, Adverse reactions | SK47B8698T |
| Magnesium Sulfate in Dextrose | MAGNESIUM SULFATE | WG Critical Care, LLC | 8da9c33f-e3cd-4026-b034-2b964401b346 | 2026-01-12 | Warnings, Adverse reactions | SK47B8698T |
| Magnesium Sulfate | MAGNESIUM SULFATE HEPTAHYDRATE | Fresenius Kabi USA, LLC | e9c10579-29f3-4889-8881-0626f63968d4 | 2026-01-12 | Warnings, Adverse reactions | SK47B8698T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.